RLAY
Price
$3.92
Change
-$0.17 (-4.16%)
Updated
Feb 21 closing price
Capitalization
656.14M
3 days until earnings call
TPST
Price
$0.86
Change
-$0.05 (-5.49%)
Updated
Feb 21 closing price
Capitalization
37.55M
24 days until earnings call
Ad is loading...

RLAY vs TPST

Header iconRLAY vs TPST Comparison
Open Charts RLAY vs TPSTBanner chart's image
Relay Therapeutics
Price$3.92
Change-$0.17 (-4.16%)
Volume$1.43M
Capitalization656.14M
Tempest Therapeutics
Price$0.86
Change-$0.05 (-5.49%)
Volume$759.45K
Capitalization37.55M
RLAY vs TPST Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. TPST commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and TPST is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (RLAY: $3.92 vs. TPST: $0.86)
Brand notoriety: RLAY and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 65% vs. TPST: 58%
Market capitalization -- RLAY: $656.14M vs. TPST: $37.55M
RLAY [@Biotechnology] is valued at $656.14M. TPST’s [@Biotechnology] market capitalization is $37.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 3 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 3 bullish, 5 bearish.
  • TPST’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TPST is a better buy in the short-term than RLAY.

Price Growth

RLAY (@Biotechnology) experienced а -2.00% price change this week, while TPST (@Biotechnology) price change was -7.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

RLAY is expected to report earnings on May 01, 2025.

TPST is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($656M) has a higher market cap than TPST($37.5M). TPST YTD gains are higher at: 3.104 vs. RLAY (-4.854). TPST has higher annual earnings (EBITDA): -33.65M vs. RLAY (-389.45M). RLAY has more cash in the bank: 840M vs. TPST (22.1M). TPST has less debt than RLAY: TPST (17.7M) vs RLAY (49.8M). RLAY has higher revenues than TPST: RLAY (10M) vs TPST (0).
RLAYTPSTRLAY / TPST
Capitalization656M37.5M1,749%
EBITDA-389.45M-33.65M1,157%
Gain YTD-4.8543.104-156%
P/E RatioN/AN/A-
Revenue10M0-
Total Cash840M22.1M3,801%
Total Debt49.8M17.7M281%
FUNDAMENTALS RATINGS
TPST: Fundamental Ratings
TPST
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYTPST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KVUE23.320.93
+4.15%
Kenvue
ARVN17.77-0.60
-3.27%
Arvinas
BMI210.25-7.92
-3.63%
Badger Meter
MTA2.97-0.18
-5.71%
Metalla Royalty & Streaming Ltd
ELEV0.61-0.04
-6.53%
Elevation Oncology

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-4.16%
XNCR - RLAY
48%
Loosely correlated
-0.32%
VCYT - RLAY
44%
Loosely correlated
-4.56%
AXON - RLAY
42%
Loosely correlated
-5.28%
BCYC - RLAY
41%
Loosely correlated
-2.83%
FHTX - RLAY
39%
Loosely correlated
-2.79%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-5.14%
PHIO - TPST
49%
Loosely correlated
-2.91%
ABCZF - TPST
48%
Loosely correlated
N/A
ORMP - TPST
30%
Poorly correlated
-3.15%
RLAY - TPST
30%
Poorly correlated
-4.16%
SWTX - TPST
30%
Poorly correlated
-2.80%
More